Inventor · disambiguated record
David A. Kummer
Also filed as: KUMMER DAVID · KUMMER DAVID A
22 granted patents·2 pending applications·118 citations·filing 2010–2023
93Inventor score
Top patents by PatentIndex Score
24 records- 0196US9221804B2Secondary alcohol quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Dec 29, 2015·35 cites·23 claims
- 0293US9290476B2Methylene linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 22, 2016·31 cites·27 claims
- 0390US10369146B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Aug 6, 2019·5 cites·13 claims
- 0489US10947252B2Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 16, 2021·3 cites·1 claims
- 0588US12024524B2Imidazopyridazines as modulators of IL-17JANSSEN PHARMACEUTICA NV·Filed 2023·Granted Jul 2, 2024·1 cites·20 claims
- 0688US9284308B2Methylene linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 15, 2016·6 cites·21 claims
- 0787US9309222B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 12, 2016·13 cites·25 claims
- 0886US9688644B2Synthesis of Tetracyclines and intermediates theretoHARVARD COLLEGE·Filed 2015·Granted Jun 27, 2017·3 cites·21 claims
- 0985US9328095B2Heteroaryl linked quinolinyl modulators of RORgammatJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 3, 2016·3 cites·5 claims
- 1085US9073829B2Synthesis of tetracyclines and intermediates theretoMYERS ANDREW G·Filed 2010·Granted Jul 7, 2015·5 cites·20 claims
- 1184US9403816B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Aug 2, 2016·3 cites·5 claims
- 1279US9624225B2Quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 18, 2017·3 cites·10 claims
- 1379US9303015B2Heteroaryl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·4 cites·24 claims
- 1477US9346782B2Alkyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2014·Granted May 24, 2016·3 cites·6 claims
- 1574US11427601B1Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Aug 30, 2022·0 cites·44 claims
- 1667US11897900B2Inhibitors of KEAP1-Nrf2 protein-protein interactionJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 13, 2024·0 cites·17 claims
- 1766US2022281823A1PHENYL AND PYRIDINYL SUBSTITUTED IMIDAZOLES AS MODULATORS OF RORgTJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 1853US11345666B2Phenyl and pyridinyl substituted imidazoles as modulators of RORγTJANSSEN PHARMACEUTICA NV·Filed 2019·Granted May 31, 2022·0 cites·8 claims
- 1951US2016136149A1HETEROARYL LINKED QUINOLINYL MODULATORS OF RORytJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 2049US10975057B26-aminopyridin-3-yl pyrazoles as modulators of RORgTJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 13, 2021·0 cites·28 claims
- 2149US10975037B2Phenyl substituted pyrazoles as modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 13, 2021·0 cites·28 claims
- 2249US10201546B2Quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 12, 2019·0 cites·18 claims
- 2343US10555941B2Alkyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Feb 11, 2020·0 cites·16 claims
- 2436US9845319B2Amide substituted thiazoles as modulators of RORytJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Dec 19, 2017·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when David A. Kummer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →